We started this event to both honor a very special man and help find a cure for kidney cancer. Through our partnership with Gateway, we are making meaningful steps toward achieving our goal.
Schaumburg, Ill. (PRWEB) November 19, 2015
Gateway for Cancer Research was the charity beneficiary at the Michael Brannan Memorial Pro-Am Charity Event. Brannan was an amateur golf champion and winner of the 2012 NCGA Senior Championship despite being diagnosed with kidney cancer in 2011. Brannan was honored and remembered at the third annual event on November 2, 2015.
Brannan’s family, dear friends and honored guests gathered with Gateway for Cancer Research to celebrate Michael’s life by doing what he loved most, playing golf. Over 60 golfers were in attendance at this third annual event which raised over $25,000 for kidney cancer research but nearly $70,000 cumulatively since its inception.
The Brannan charity supports Gateway for its mission to fund meaningful and breakthrough clinical trials worldwide that help people living with cancer to feel better, live longer and conquer cancer TODAY!
Gateway is funding a kidney cancer clinical trial, Combining NeoVax, a personalized neoantigen vaccine, with ipilimumab to treat advanced clear cell renal carcinoma. To read more: https://www.gatewaycr.org/research/funded-clinical-trials/Kidney-Cancer/Dr-Toni-Choueiri/6171.
"We started this event to both honor a very special man and help find a cure for kidney cancer. Through our partnership with Gateway, we are making meaningful steps toward achieving our goal." – said Amy Belew, Tournament Director.
Michael Brannan Memorial Pro-Am charity event sponsors included TPC Sontebrae, PING, East Bay BMW and Kepler’s Golf Repair.
# # #
About Gateway for Cancer Research℠
Gateway for Cancer Research is a nonprofit 501(c)(3) organization committed to funding innovative cancer research studies that help today’s cancer patients to feel better, live longer and conquer cancer TODAY!. Thanks to generous underwriting by Cancer Treatment Centers of America®, 99 cents of every dollar Gateway receives directly funds Phase I and Phase II cancer clinical trials at leading research institutions across the country and abroad. Since 1991 Gateway has supported more than 140 clinical trials and funded millions in leading-edge research, including blending the best of conventional, and complementary and alternative therapies. Get involved today by visiting GatewayCR.org, like us on Facebook at facebook.com/demandcures and join the conversation on Twitter @DemandCures. #BeAGateway.